Genmab shows safety data for ovarian cancer drug combination

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. NAVN
6. DFTX
7. CNC
8. KFY
9. SPY
10. MU

Go back to Genmab shows safety data for ovarian cancer drug combination
(NASDAQ: GMAB) Delayed: 25.61 --0 (-0%)
Previous Close $25.61    52 Week High $ 
Open $25.61    52 Week Low $ 
Day High $25.61    P/E N/A 
Day Low $25.61    EPS $ 
Volume 5,665